[Clinical analyses of XXXX with intractable @entity1415 originated from deep-seated nasal cavity].

@entity1 @entity101 @entity6 @entity548 @entity1415
OBJECTIVE: To investigate the clinical features and management of intractable deep-seated @entity1415 . METHODS: Clinical data were analyzed retrospectively in 195 @entity1 with intractable deep-seated @entity1415 treated in Affiliated Hospital of Qingdao College between June 2008 and June 2014. The analyses included common risk factors, @entity548 sites, treatments and therapeutic effects. SPSS 17.0 software was used to analyze the data. RESULTS: There were 162 males and 33 females, aged from 15 to 88 years old (mean 52    16 years). One hundred and eighty-seven cases (95.9%) were unilateral and 8 cases (4.1%) were bilateral. One hundred and twenty-six cases (64.6%) had the history of @entity101 or blood pressure higher than normal on admission. Eight @entity1 were cured by nasal packing and appropriate drugs, and 187 @entity1 were treated by endoscopy and electrocoagulation. The numbers of treatment needed to stop @entity548 were 1 time in 184 cases (98.4%), 2 times in 3 cases (1.6%). Thirteen cases did not have certain @entity548 point, while the other 174 had certain one or more @entity548 sites. The rewarded @entity548 sites were 222, which were found in the following different sites: posterior inferior nasal meatus (33.3%, 74 /222), olfactory cleft of nasal septum (26.6%, 59/222), the root of the middle turbinate (14.0%, 31/222), and so on. @entity101 and @entity6 were risk factors (OR value was 3.411, 7.142, both P < 0.05). CONCLUSIONS: Intractable deep-seated @entity1415 are mainly found in males and are almost unilatera1. @entity101 and @entity6 are the common risk factor. The most effective and safe treatment for intractable deep-seated @entity1415 is electrocoagulation under nasal endoscopy.
